Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 [JUNIPER]
| The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02403323 |
Recruitment Status : Recruiting First Posted : March 31, 2015 Last Update Posted : December 2, 2021 See Contacts and Locations |
Sponsor:
Hoffmann-La Roche
Information provided by [Responsible Party]:
Hoffmann-La Roche